CORMEDIX INC.

CRMD

Delayed - 05/17 04:00:01 pm
3.82USD	+5.82%

Turn to zoom

Prev.	3.8200
Open	3.6800
High	3.9370
Low	3.6800
Volume	419 183

4d ago	CORMEDIX INC. Management's Discussion and Analysis of Financial Condition...
4d ago	Transcript : CorMedix Inc., Q1 2022 Earnings Call, May 12, 2022
4d ago	CorMedix: Q1 Earnings Snapshot
4d ago	CORMEDIX INC. : Results of Operations and Financial Condition, Other Events,...

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bearish	Bearish
Resistance	4,21	4,21	5,05
Spread/Res.	-14%	-14%	-29%
Spread/Supp.	21%	21%	13%
Support	2,98	2,98	3,19

Sales 2022	0,64 M - -
Net income 2022	-36,5 M - -
Net cash 2022	118 M - -
P/E ratio 2022	-4,15x
Yield 2022	-

Capitalization	141 M 141 M -
EV / Sales 2022	37,0x
EV / Sales 2023	2,56x
Nbr of Employees	30
Free-Float	97,3%

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its lead product candidate, DefenCath, for...

>> Read more

Sector :

Specialty & Advanced Pharmaceuticals

Calendar :

2022-08-16 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	BUY
Number of Analysts	3
Last Close Price	3,61 $
Average target price	22,00 $
Spread / Average Target	509%